If you're going to attempt to bash the stock you should be aware that you've chosen a particularly unfortunate angle.
Most here know that the standard study for an inhaled antibiotic these days entails three cycles - each cycle consisting of a four-week therapy phase followed by a four week break. Total study period - 24 weeks.
There's only ever been one instance of data being submitted to the FDA for an inhaled antibiotic studied over a longer period. In that case the study period was 72 weeks.
You'll never guess the name of that antibiotic :-)
That sound you've been hearing is not people laughing WITH you.